READ ABOUT RECENT RESEARCH EFFORTS AT DUKE!

Reprinted from the Rory David Deutsch Foundation Newsletter

Winter, 2001

.

Rory Gives Duke Hope

The Rory David Deutsch Brain Tumor Research Program at the Brain Tumor Center of Duke University was launched last spring to support laboratory and clinical studies in the area of pediatric brain tumors. With the help of funds from the Rory David Deutsch Foundation, the program is now undertaking clinical trials of new chemotherapy treatments that have been found to treat pediatric gliomas in lab studies. In addition, the world-renowned cancer center is coducting laboratory research to identify specific genes that may play a role in tumor growth. The Duke team is also developing vaccines for childhood gliomas.

The Rory David Deutsch Foundation recently made a research grant in the amount of $2 million to be paid over ten years, ensuring the perpetuity of this program. This will enable the Duke Brain Tumor Center to explore new approaches against childhood gliomas that would not be possible without the Foundation's support.

"Because of the Foundation's support and general advances taking place in cancer biology, I feel confident that within my lifetime effective treatment of childhood gliomas will become a reality," says Dr. Darell Bigner, leader of the Neuro-Oncology Program and deputy director of the Duke Comprehensive Cancer Center.

"With the help of the Foundation, we can accelerate our progress and move closer to successfully treating and ultimately finding a cure for this disease," explains Dr. Henry Friedman, co-director of the Clinical Neuro-Oncology Program at the Brain Tumor Center.

Complete Article with more information about the treatment and studies.